ENVECSI

Serial Number 97463189
732

Registration Progress

Application Filed
Jun 17, 2022
Under Examination
Oct 3, 2023
Approved for Publication
Aug 8, 2023
Published for Opposition
Aug 8, 2023
Registered

Attorney Assistance

Statement of Use Due - Extension 3 Granted
Due: Oct 03, 2025 65 days

Trademark Image

ENVECSI

Basic Information

Serial Number
97463189
Filing Date
June 17, 2022
Published for Opposition
August 8, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
732
Status Date
Mar 27, 2025
Application
Pending
Classes
005

Rights Holder

JOHNSON & JOHNSON

03
Address
One Johnson & Johnson Plaza
New Brunswick, NJ 08933

Ownership History

JOHNSON & JOHNSON

Original Applicant
03
New Brunswick, NJ

JOHNSON & JOHNSON

Owner at Publication
03
New Brunswick, NJ

Legal Representation

Attorney
Cheryl L. Foytlin

USPTO Deadlines

Next Deadline
65 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
October 03, 2025
Extension Available
Until October 03, 2024

Application History

26 events
Date Code Type Description Documents
Mar 28, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 27, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
Mar 27, 2025 EXT3 S SOU EXTENSION 3 FILED Loading...
Mar 27, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 26, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 26, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Sep 26, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Sep 26, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 21, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 20, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 20, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 20, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 3, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 8, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 8, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 19, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 29, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 1, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 1, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 1, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 29, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 29, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 29, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 29, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 5, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 21, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, pulmonary diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, cerebrovascular diseases, ophthalmic diseases, and respiratory diseases; anti-allergics; vaccines

Additional Information

Translation
The wording "ENVECSI" has no meaning in a foreign language.

Classification

International Classes
005